Rewards

Vertex Pharmaceuticals Inc (VRTX)

Underlying price

$496.54

+2.33% today

Stock stats

Market cap
$122B
Previous close
$485.22
Open
$490.45
Day's range
$487.54 – $497.99
52-week range
$403.16 – $560.25
Volume
504K
Avg volume
1.03M
P/E ratio
29.17

About Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

Ticker
VRTX
Asset class
Equity
Tokenized by
1 issuer
Sector
Healthcare
Industry
Pharmaceutical Preparations
Employees
6,400
Website
vrtx.com

Vertex Pharmaceuticals Inc FAQ

VRTX is Vertex Pharmaceuticals Inc stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Vertex Pharmaceuticals Inc trades here as one token.